Biogen Pharmachem Industries Ltd.

View in App
0.65 -0.01 ▼-1.5%

09 June 2023, 04:01:00 PM
Volume: 1,146,759

Company Profile

View details >>
Sector Finance Compare with Sector peers
Industry Finance - Others Compare with Industry peers
Website http:// www.biogenpharma.shop
Market Cap 42.42 Cr.
Enterprise Value(EV) 42.29 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 0.01 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 93.02 Trailing Twelve Months Ending 2023-03
Industry PE 34.04 Trailing Twelve Months Ending 2023-03
Book Value / Share 0.84 Trailing Twelve Months Ending 2023-03
Price to Book Value 0.78 Calculated using Price: 0.65
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 65.26 Cr. 652,603,000 Shares
FaceValue 1
About Biogen Pharmachem Industries Ltd.
Sun Techno Overseas Ltd., formerly Wellworth Overseas Limited, is an India-based company.In 2011 the company changed its name from Wellworth Overseas Ltd. to Sun Techno Overseas Ltd.

Biogen Pharmachem Industries Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Biogen Pharmachem Industries Ltd. Performance

View details >>
1 Day
-1.52%
1 Week
+3.17%
1 Month
-5.80%
3 Month
-5.80%
6 Month
-21.69%
1 Year
-38.68%
2 Year
+132.14%
5 Year
+182.61%
10 Year
+441.67%

Biogen Pharmachem Industries Ltd. Fundamental Ratios

View details >>
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -0.21 -0.22 -0.05 -0.20 -11.40 -0.01 -0.21 -2.92 -0.02
Return on Capital Employed (%) -0.14 -0.14 -0.04 -0.19 -11.33 -0.01 -0.21 -2.91 -0.02
Return on Assets (%) -0.14 -0.13 -0.04 -0.18 -11.01 -0.01 -0.21 -2.91 -0.02

Biogen Pharmachem Industries Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 61 61 61 61 54 54 56 54 54 55
Non Curr. Liab. 2 9 8 2 2 2 0
Curr. Liab. 61 3 0 0 0 1 0 0 1 0
Minority Int.
Equity & Liab. 123 73 69 63 56 58 56 54 55 55
Non Curr. Assets 76 45 55 63 49 50 48 52 53 55
Curr. Assets 47 29 14 0 7 8 8 3 2 0
Misc. Exp. not W/O 0
Total Assets 123 73 69 63 56 58 56 54 55 55

Biogen Pharmachem Industries Ltd. Profit and Loss

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. TTM
Net Sales 1 2 2 -2
Other Income 0 0 2
Total Income 0 1 2 2 1
Total Expenditure 0 0 0 0 -7 -1 0 -3 -2 0
PBIDT 0 0 0 0 -7 0 -2 0 0
Interest
Depreciation
Taxation
Exceptional Items
PAT 0 0 0 0 -7 0 -2 0 0
Adjusted EPS 0 0 0

Biogen Pharmachem Industries Ltd. Cash Flow

View details >>
Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 22 0 -7 5 0 -14 0 -1 4 1
Cash Fr. Inv. -46 -9 17 17 4 14 -1 2 -4 -1
Cash Fr. Finan. 24 10 -11 -22 -4 -1 1 0 0
Net Change 0 1 -1 0 0 0 0 0
Cash & Cash Eqvt 0 1 0 0 0 0 0 0

Biogen Pharmachem Industries Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Public 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Biogen Pharmachem Industries Ltd. Announcements

View details >>
Fri, 19 May 2023
Compliances-Reg.24(A)-Annual Secretarial Compliance
In compliance with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated February 8 2019 please find enclosed herewith Annual Secretarial Compliance Report of the Company for the financial year ended on 31st March 2023 issued by secretarial auditor Mr. Haresh Kapuriya Practicing Company Secretaries. You are requested to take the same on your record. Thanking you.
Mon, 08 May 2023
Board Meeting Outcome for Outcome Of The Board Meeting Of The Board Held On 8Th May 2023.
This is to inform you that Outcome of the Board Meeting of the Company held on Monday 8th May 2023 in accordance with SEBl (Listing Obligations and Disclosures Requirements) Regulations 2015 has been approved by the Board of Directors of the Company and taken on record inter-alia the following items;
1.) Consideration and Approval of Audited Financial Result for the Year ended 31st March 2023.

2.) Independent Audit Report in pursuance with Regulation 33 of SEBI (LODR) Regulations 2015 for the F.Y. 31st March 2023.

Further we hereby declare that the Auditor of the Company has issued the Audit report under the Companies Act 2013 and financial results as prepared under SEBI (Listing obligations and Disclosure Requirements) Regulations 2015 for the financial year ended on March 31 2023 with unmodified opinion.
The board meeting concluded on 05:30 P.M

Request you to kindly take on record the same
Mon, 08 May 2023
Regulations 30 33 And Other Applicable Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
This is to inform you that Outcome of the Board Meeting of the Company held on Monday 8th May 2023 in accordance with SEBl (Listing Obligations and Disclosures Requirements) Regulations 2015 has been approved by the Board of Directors of the Company and taken on record inter-alia the following items;
1.) Consideration and Approval of Audited Financial Result for the Year ended 31st March 2023.

2.) Independent Audit Report in pursuance with Regulation 33 of SEBI (LODR) Regulations 2015 for the F.Y. 31st March 2023.

Further we hereby declare that the Auditor of the Company has issued the Audit report under the Companies Act 2013 and financial results as prepared under SEBI (Listing obligations and Disclosure Requirements) Regulations 2015 for the financial year ended on March 31 2023 with unmodified opinion.
The board meeting concluded on 05:30 P.M

Request you to kindly take on record the same.

Biogen Pharmachem Industries Ltd. Technical Scans

View details >>
Fri, 09 Jun 2023
Opening at High Opening at High
High Decrease in 1 Month High Decrease in 1 Month
High Decrease in 6 Months High Decrease in 6 Months
High Decrease in 1 Year High Decrease in 1 Year
High Increase in 2 Years High Increase in 2 Years

Biogen Pharmachem Industries Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Housing Development Finance Corporation Ltd. 489,644.05 2,651.95 -0.1%
Bajaj Finance Ltd. 426,351.55 7,036.45 +0.4%
Life Insurance Corporation of India 380,606.74 601.75 -0.3%
Bajaj Finserv Ltd. 233,514.71 1,466.05 -0.1%
HDFC Life Insurance Co Ltd. 125,023.31 581.60 -2.0%
SBI Life Insurance Company Ltd. 123,175.97 1,233.80 -0.3%
Cholamandalam Investment and Finance Company Ltd. 87,619.63 1,061.00 0.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Housing Development Finance Corporation Ltd. Consolidated 2023-03 18.72 2,651.95 -0.1%
Bajaj Finance Ltd. Consolidated 2023-03 37.05 7,036.45 +0.4%
Life Insurance Corporation of India Consolidated 2023-03 10.57 601.75 -0.3%
Bajaj Finserv Ltd. Consolidated 2023-03 36.39 1,466.05 -0.1%
HDFC Life Insurance Co Ltd. Consolidated 2023-03 91.37 581.60 -2.0%
SBI Life Insurance Company Ltd. Standalone 2023-03 71.59 1,233.80 -0.3%
Cholamandalam Investment and Finance Company Ltd. Consolidated 2023-03 32.73 1,061.00 0.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Housing Development Finance Corporation Ltd. Consolidated 2023-03 2.43 2,651.95 -0.1%
Bajaj Finance Ltd. Consolidated 2023-03 7.84 7,036.45 +0.4%
Life Insurance Corporation of India Consolidated 2023-03 8.20 601.75 -0.3%
Bajaj Finserv Ltd. Consolidated 2023-03 5.03 1,466.05 -0.1%
HDFC Life Insurance Co Ltd. Consolidated 2023-03 9.64 581.60 -2.0%
SBI Life Insurance Company Ltd. Standalone 2023-03 9.53 1,233.80 -0.3%
Cholamandalam Investment and Finance Company Ltd. Consolidated 2023-03 6.08 1,061.00 0.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Housing Development Finance Corporation Ltd. Consolidated 2022-03 2.85 2,651.95 -0.1%
Bajaj Finance Ltd. Consolidated 2022-03 3.81 7,036.45 +0.4%
Life Insurance Corporation of India Consolidated 2022-03 0.00 601.75 -0.3%
Bajaj Finserv Ltd. Consolidated 2022-03 4.03 1,466.05 -0.1%
HDFC Life Insurance Co Ltd. Consolidated 2022-03 0.04 581.60 -2.0%
SBI Life Insurance Company Ltd. Standalone 2022-03 0.00 1,233.80 -0.3%
Cholamandalam Investment and Finance Company Ltd. Consolidated 2022-03 5.91 1,061.00 0.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Housing Development Finance Corporation Ltd. Consolidated 2022-03 14.43 2,651.95 -0.1%
Bajaj Finance Ltd. Consolidated 2022-03 17.59 7,036.45 +0.4%
Life Insurance Corporation of India Consolidated 2022-03 45.16 601.75 -0.3%
Bajaj Finserv Ltd. Consolidated 2022-03 22.03 1,466.05 -0.1%
HDFC Life Insurance Co Ltd. Consolidated 2022-03 11.08 581.60 -2.0%
SBI Life Insurance Company Ltd. Standalone 2022-03 14.00 1,233.80 -0.3%
Cholamandalam Investment and Finance Company Ltd. Consolidated 2022-03 20.29 1,061.00 0.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Housing Development Finance Corporation Ltd. Consolidated 2022-03 14.43 2,651.95 -0.1%
Bajaj Finance Ltd. Consolidated 2022-03 17.59 7,036.45 +0.4%
Life Insurance Corporation of India Consolidated 2022-03 45.16 601.75 -0.3%
Bajaj Finserv Ltd. Consolidated 2022-03 22.03 1,466.05 -0.1%
HDFC Life Insurance Co Ltd. Consolidated 2022-03 11.08 581.60 -2.0%
SBI Life Insurance Company Ltd. Standalone 2022-03 14.00 1,233.80 -0.3%
Cholamandalam Investment and Finance Company Ltd. Consolidated 2022-03 20.29 1,061.00 0.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Housing Development Finance Corporation Ltd. Consolidated 2022-03 135,925.76 2,651.95 -0.1%
Bajaj Finance Ltd. Consolidated 2022-03 31,658.98 7,036.45 +0.4%
Life Insurance Corporation of India Consolidated 2022-03 601.75 -0.3%
Bajaj Finserv Ltd. Consolidated 2022-03 68,406.08 1,466.05 -0.1%
HDFC Life Insurance Co Ltd. Consolidated 2022-03 581.60 -2.0%
SBI Life Insurance Company Ltd. Standalone 2022-03 1,233.80 -0.3%
Cholamandalam Investment and Finance Company Ltd. Consolidated 2022-03 10,140.75 1,061.00 0.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Housing Development Finance Corporation Ltd. Consolidated 2022-03 24,042.13 2,651.95 -0.1%
Bajaj Finance Ltd. Consolidated 2022-03 7,028.23 7,036.45 +0.4%
Life Insurance Corporation of India Consolidated 2022-03 4,124.71 601.75 -0.3%
Bajaj Finserv Ltd. Consolidated 2022-03 8,313.53 1,466.05 -0.1%
HDFC Life Insurance Co Ltd. Consolidated 2022-03 1,326.93 581.60 -2.0%
SBI Life Insurance Company Ltd. Standalone 2022-03 1,506.00 1,233.80 -0.3%
Cholamandalam Investment and Finance Company Ltd. Consolidated 2022-03 2,158.89 1,061.00 0.0%

Biogen Pharmachem Industries Ltd. FAQ's

What is Biogen Pharmachem share price?
Can I buy Biogen Pharmachem shares now?
What is the Market Cap of Biogen Pharmachem?
What are the key metrics to analyse Biogen Pharmachem?
What is the 52 Week High and Low of Biogen Pharmachem?
What is the trend of Biogen Pharmachem share price?